2021 ESC/EACTS Guidelines for the management of valvular heart disease

2021 ESC/EACTS Guidelines for the management of valvular heart disease https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/2021-Valvular-Heart-Disease
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-and-Chronic-Heart-Failure
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/2021-ESC-Guidelines-on-cardiovascular-disease-prevention-in-clinical-practice
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Pulmonary-Hypertension-Guidelines-on-Diagnosis-and-Treatment-of
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Ventricular-Arrhythmias-and-the-Prevention-of-Sudden-Cardiac-Death
2022 ESC Guidelines on cardio-oncology developed

2022 ESC Guidelines on cardio-oncology developed https://academic.oup.com/eurheartj/article/43/41/4229/6673995
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/ESC-Guidelines-on-non-cardiac-surgery-cardiovascular-assessment-and-managem
Effects of β2-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trial

Effects of β2-receptor stimulation by indacaterol in chronic heart failure treated with selective or non-selective β-blockers: a randomized trial Contini M, Spadafora E, Barbieri S, Gugliandolo P, Salvioni E, Magini A, Apostolo A, Palermo P, Alimento M, Agostoni P.Sci Rep. 2020 Apr 28;10(1):7101. doi: 10.1038/s41598-020-62644-1.PMID: 32345990 Free PMC article. Clinical Trial.
Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID-19

Cardiac patient care during a pandemic: how to reorganise a heart failure unit at the time of COVID-19 Agostoni P, Mapelli M, Conte E, Baggiano A, Assanelli E, Apostolo A, Alimento M, Berna G, Guglielmo M, Muratori M, Susini F, Palermo P, Pezzuto B, Salvioni E, Sudati A, Vignati C, Merlino L.Eur J Prev Cardiol. 2020 […]
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction

Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction Salvioni E, Corrà U, Piepoli M, Rovai S, Correale M, Paolillo S, Pasquali M, Magrì D, Vitale G, Fusini L, Mapelli M, Vignati C, Lagioia R, Raimondo R, Sinagra G, Boggio F, Cangiano L, Gallo G, Magini A, Contini […]